The multi-face expression of familial mediterranean fever in the child

European Review for Medical and Pharmacological Sciences

Volumn 10, Issue 4, 2006, Pages 163-171

  Rigante, Donato ^a   La Torraca, I ^a   Ansuini, V ^a   Compagnone, A ^a   Salli A ^a   Stabile, A ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Child; Familial Mediterranean fever

Indexed keywords

ALPHA INTERFERON; CASPASE INHIBITOR; COLCHICINE; ETANERCEPT; INFLIXIMAB; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; METHYLPREDNISOLONE; PROTEIN MEFV; PYRIN; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; REPRESSOR PROTEIN; THALIDOMIDE; TUMOR NECROSIS FACTOR DERIVATIVE; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; CYTOSKELETON PROTEIN; MARENOSTRIN;

ARTHRITIS; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; DISEASE EXACERBATION; DRUG DOSE REGIMEN; EPIDEMIOLOGICAL DATA; FAMILIAL MEDITERRANEAN FEVER; GENE MUTATION; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; LEUKOCYTE MIGRATION; PATHOGENESIS; PHENOTYPE; RELAPSE; SEROSA; AMYLOIDOSIS; CHILD; DIFFERENTIAL DIAGNOSIS; GENETICS; MUTATION; PERIODICITY; QUALITY OF LIFE; REVIEW;

AMYLOIDOSIS; ANTI-INFLAMMATORY AGENTS; CHILD; COLCHICINE; CYTOSKELETAL PROTEINS; DIAGNOSIS, DIFFERENTIAL; FAMILIAL MEDITERRANEAN FEVER; GENOTYPE; HUMANS; MUTATION; PERIODICITY; QUALITY OF LIFE;

EID: 33748568520     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (82)

1. Stojanov S, Kastner DL. Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol 2005; 17: 586-599.
2. Kobayashi S. Hereditary periodic fever syndromes: autoinflammatory diseases. Intern Med 2005; 44: 694-695.
3. Padeh S. Periodic fever syndromes. Pediatr Clin North Am 2005; 52: 577-609.
4. Aringer M. Periodic fever syndromes: a clinical overview. Acta Med Austriaca 2004; 31: 8-12.
5. Shoham N, Centola M. Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc Natl Acad Sci USA 2003; 100: 13501-13506.
6. Picco P, Ceccherini I, Martini A. the inherited periodic fever syndromes. Ital J Pediatr 2002; 28: 285-291.
7. Janeway T, Mosenthal H. An unusual paroxysmal syndrome, probably allied to recurrent vomiting with a study of the nitrogen metabolism. Trans Ass Am Phys 1908; 23: 504-518.
8. Siegal S. Benign paroxysmal polyserositis. Analysis of fifty cases. Am J Med 1964; 36: 893-918.
9. Mamou H, Cattan R. La maladle periodique sur 24 cases personnels dont 8 compliques de nephropathies. Sem Hop Paris 1952; 28: 1062-1070.
10. Reimann H, Moadie J, Semerdjian S, Sahyoun PF. Periodic peritonitis; heredity and pathology: report of seventy-two cases. JAMA 1954; 154: 1254-1259.
11. Heller H, Sohar E, Sherf L. Familial Mediterranean Fever. AMA Arch Int Med 1958; 102: 50-71.
12. Cook GC. Periodic disease, recurrent polyserositis, familial Mediterranean fever or simply "FMF". Q J Med 1986; 60: 819-823.
13. Babior BM, Matzner Y. The familial Mediterranean fever gene-cloned at last. N Engl J Med 1997; 337:1548-1549.
14. Stehlik C, Reed JC. The pyrin connection: novel players in innate immunity and inflammation. J Exp Med 2004; 6: 551-558.
15. Booth DR, Gillmore JD, Booth SE, Pepys MB, Hawkins PN. Pyrin/marenostrin mutations in familial Mediterranean fever. QJM 1998; 91: 603-606.
16. Touitou I. The spectrum of familial Mediterranean fever mutations. Eur J Hum Genet 2001; 9: 473-483.
17. Kilcline C, Shinkai K, Bree A, Modica R, Von Scheven E, Frieden I.J. Neonatal onset multisystem inflammatory disorder: the emerging role of pyrin genes in autoinflammatory diseases. Arch Dermatol 2005; 141: 242-247.
18. Ozen S. Familial Mediterranean fever: revisiting an ancient disease. Eur J Pediatr 2003; 162: 449-454.
19. Aksentuevich I, Torosyan Y, Samuels J, Centola M, Pras E, Chae JJ, Oddoux C, Wood G, Azzaro MP, Palumbo G, Giustousi R, Pras M, Cistrer H, Kastner DL. Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am J Hum Genet 1999; 64: 949-962.
20. Konstantopoulos K, Kanta A, Lilakos K. Familial Mediterranean fever. N Z Med J 2004; 117: U1007.
21. Kotone-Miyahara Y, Takaori-Kondo A, Fukunaga K, Goto M, Hayashino Y Miki M, Takayama H, Sasada M, Uchiyama T. E148Q/M6941 mutation in 3 Japanese patients with familial Mediterranean fever. Int J Hematol 2004; 79: 235-237.
22. Gershoni-Baruch R, Shinawi M, Leah K, Badarnah K, Brik R. Familial Mediterranean fever: prevalence, penetrance and genetic drift. Eur J Hum Genet 2001; 9: 634-637.
23. Pras M. Familial Mediterranean fever: past, present and future. Clin Exp Rheum 2002; 20(Suppl. 26): S1-S66.
24. Piazza A, Cappello N, Olivetti E, Rendine S. A genetic history of Italy. Ann Hum Genet 1988; 52: 203-213.
25. The French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet 1997; 17: 25-31.
26. Kastner DL. Familial Mediterranean fever: the genetics of inflammation. Hosp Pract 1998; 33: 131-140.
27. Pras E, Aksentijevich I, Gruberg L, Balow JE Jr, Prosen L, Dean M, Steinberg AD, Pras M, Kastner DL. Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16. N Engi J Med 1992; 326:1509-1513.
28. The International FMF Consortium. Ancient missense mutations in a new member of the Ro-Ret gene family are likely to cause familial Mediterranean fever. Cell 1997; 90: 797-807.
29. Manji GA, Wang L, Geddes BJ, Brown M, Merriam S, Al-Garawi A, Mak S, Lora JM, Briskin M, Jurman M, Cao J, DiStefano PS, Bertin J. PYPAF1, a PYRIN-containing Apafl-like protein that assembles with ASC and regulates activation of NF-kappa B. J Biol Chem 2002; 277:11570-11575.
30. Dowds TA, Masumoto J, Chen FF, Ogura Y, Inohara N, Nunez G. Regulation of cryopyrin/Pypaf1 signalling by pyrin, the familial Mediterranean fever gene product. Biochem Biophys Res Commun 2003; 302: 575-580.
31. Richards N, Schaner P, Diaz A, Stuckey J, Shelden E, Wadhwa A, Gumucio DL. Interaction between pyrin and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis. J Biol Chem 2001; 276: 39320-39329.
32. Matzner Y, Ayesh SK, Hochner-Celniker D, Ackerman Z, Ferne M. Proposed mechanism of the inflammatory attacks in familial Mediterranean fever. Arch Intern Med 1990; 150: 1289-1291.
33. Matzner Y, Partridge R, Levy M, Babior BM. Diminished activity of a chemotactic inhibitor in synovial fluids from patients with familial Mediterranean fever. Blood 1984; 63: 629-633.
34. Matzner Y, Brzezinski A. C5a-inhibitor deficiency in peritoneal fluids from patients with familial Mediterranean fever. N Engl J Med 1984; 311: 287-290.
35. Matzner Y, Abedat S, Shapiro E, Eisenberg S, Bar-Gil-Shitrit A, Stepensky P, Calco S, Azar Y, Urieli-Shoval S. Expression of the familial Mediterranean fever gene and activity of the C5a inhibitor in human primary fibroblast cultures. Blood 2000; 96: 727-731.
36. Chae JJ, Komarow HD, Cheng J, Wood G, Raben N, Liu PP, Kastner DL. Targeted disruption of pyrin, the familial Mediterranean fever protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell 2003; 11: 591-604.
37. Werts C, Girardin SE, Philpott DJ. TIR, CARD and PYRIN: three domains for an antimicrobial triad. Cell Death Differ 2006; 13: 798-815.
38. Gumucio DL, Diaz A, Schaner P, Richards N, Babcock C, Schaller M, Cesena T. Fire and ice: the role of pyrin domain-containing proteins in inflammation and apoptosis. Clin Exp Rheum 2002; 20: S45-S53.
39. Centola M, Wood G, Frucht DM, Galon J, Aringer M, Farrell C, Kingma DW, Horwitz ME, Mansfield E, Holland SM, O'Shea JJ, Rosenberg HF, Malech HL, Kastner DL. The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood 2000; 95: 3223-3231.
40. Bagci S, Toy B, Tuzun A, Ates Y, Asian M, Inal A, Gulsen M, Karaeren N, Dagalp K. Continuity of cytokine activation in patients with familial Mediterranean fever. Clin Rheumatol 2004; 23: 333-337.
41. Ozen S. A new insight into periodic and recurrent fever: clinical aspects and differential diagnosis of periodic fever syndromes. Riv Ital Pediatr 2001; 27: 616-617.
42. Dode C, Pecheux C, Cazeneuve C, Cattan D, Dervichian M, Goossens M, Delpech M, Amselem S, Grateau G. Mutations in the MEFV gene in a large series of patients with a clinical diagnosis of familial Mediterranean fever. Am J Med Genet 2000; 92: 241-246.
43. Tunca M, Akar S, Onen F, et al. Familial Mediterranean fever in Turkey: results of a Nationwide Multicenter Study. Medicine 2005; 84: 1-11.
44. Konstantopoulos K, Kanta A, Deltas C, Atamian V Mavrogianni D, Tzjoufas AG, Kollainis I, Ritis K, Moutsopoulos HM. Familial Mediterranean fever associated pyrin mutations in Greece. Ann Rheum Dis 2003; 62: 479-481.
45. Konstantopoulos K, Kanta A. Familial Mediterranean fever seems to be not uncommon in Greece. Eur J Hum Genet 2004; 12: 85-86.
46. Deltas CC, Mean R, Rossou E, Costi C, Koupepidou P, Hadjiyanni I, Hadjiroussos V, Petrou P, Pierides A, Lamnisou K, Kopticles M. Familial Mediterranean fever is a frequent disease in the Greek-Cypriot population of Cyprus. Genet Test 2002; 6:15-21.
47. Booth DR, Lachmann HJ, Gillmore JD, Booth SE, Hawkins PN. Prevalence and significance of the familial Mediterranean fever gene mutation encoding pyrin E1480. QJM 2002; 95: 332-333.
48. Ben-Chetrit E, Lerer I, Malamud E, Domingo C, Abeliovich D. The E148Q mutation in the MEFV gene: is it a disease-causing-mutation or a sequence variant? Hum Mutat 2000; 15: 385-386.
49. Bernot A, Da Silva C, Petit JL, Cruaud C, Caloustian C, Castet V, Ahmed-arab M, Dross C, Dupont M, Cattan D, Smaoui N, Dode C, Pecheux C, Nedelec B, Medaxian J, Rozenbaum M, Rosner I, Delpech M, Grateau G, Demaille J, Weissenbach J, Touitou I. Non-founder mutations in the MEFV gene estabilish this gene as the cause of familial Mediterranean fever. Hum Mol Genet 1998; 7: 1317-1325.
50. Shinar Y, Livneh A, Langevitz P, Zaks N, Aysentuevich I, Koziol DE, Kastner DL, Pras M, Pras E. Geno-type-phenotype assessment of common geno-types among patients with familial Mediterranean fever. J Rheumatol 2000; 27: 1703-1707.
51. Dewalle M, Domingo C, Rozenbaum M, Ben-Chetrit E, Catian D, Bernot A, Dross C, Dupont M, Notar-Nicola C, Levy M, Rosner I, Demaille J, Touitou I. Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever. Eur J Hum Genet 1998; 6: 95-97.
52. Akar N, Hasipek M, Akar E, Ekim M, Yalcinkaya F, Cakar N. Serum amyloid A1 and tumor necrosis factor-alpha alleles in Turkish familial Mediterranean fever patients with and without amyloidosis. Amyloid 2003; 10:12-16.
53. Yalcinkaya F, Akar N, Misirlioglu M. Familial Mediterranean fever-amyloidosis and the V726A mutation. N Engl J Med 1998; 338: 993-994.
54. Cazeneuve C, Sarkisian T, Pecheux C, Dervichian M, Nedelec B, Reinert P, Ayvazyan A, Kouyoumdjian JC, Ajrapetyan H, Delpech M, Goossens M, Dode C, Grateau G, Amselem S. MEFV gene analysis in Armenian patients with Familial Mediterranean fever: diagnostic value and unfavourable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet 1999; 65: 88-97.
55. Mimouni A, Magal N, Stoffman N, et al. Familial Mediterranean fever: effect of genotype and ethnicity on inflammatory attacks and amyloidosis. Pediatrics 2000; 105: E70.
56. Tekin M, Yalcinkaya F, Cakar N, Akar N, Misirlioglu M, Tastan H, Tumer N. MEFV mutation in multiplex families with familial Mediterranean fever: is a particular genotype necessary for amyloidosis? Clin Genet 2000; 57: 430-434.
57. Touitou I, Picot MC, Domingo C, Notarnicola C, Cattan D, Demaille J, Kone-paut I. The MICA region determines the first modifier locus in familial Mediterranean fever. Arthritis Rheum 2001; 44: 163-169.
58. Cazeneuve C, Ajrapetyan H, Papin S, Roudot-Thoraval F, Genevieve D, Mndjoyan E, Papazian M, Sarkisian A, Babloyan A, Boissier B, Duquesnoy P, Kouyoumdjian JC, Girodon-Boulandet E, Grateau G, Sarkisian T, Amselem S. Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet 2000; 67:1136-1143.
59. Yalcinkaya F Cakar N, Misirlioglu M, ET aL. Geno-type-phenotype correlation in a large group of Turkish patients with familial Mediterranean fever: evidence for mutation-indipendent amyloidosis. Rheumatology 2000; 39: 67-72.
60. Yilmaz E, Balci B, Kutlay S, Ozen S, Erturk S, Oner A, Besbas N, Bakkaloglu A. Analysis of the modifying effects of SAA1,SAA2 and TNF-alpha gene polymorphisms on development of amyloidosis in familial Mediterranean fever patients. Turk J Pediatr 2003; 45: 198-202.
61. Gershoni-Baruch R, Brik R, Zacks N, Shinawi M, Lidar M, Livneh A. The contribution of genotypes at the MEFV and SAA1 loci to amyloiclosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum 2003; 48: 1149-1155.
62. Livneh A, Langevitz P, Zemer D, Padeh S, Migdal A, Sohar E, Pras M. The changing face of familial Mediterranean fever. Semin Arthritis Rheum 1996; 26: 612-627.
63. Tamir N, Langevitz P, Zemer D, Pras E, Shinar Y, Padeh S, Zaks N, Pras M, Livneh A. Late-onset familial Mediterranean fever: a subset with distinct clinical, demographic and molecular genetic characteristics. Am J Med Genet 1999; 87: 30-35.
64. Rozenbaum M, Rosner I. The clinical features of familial Mediterranean fever of elderly onset. Clin Exp Rheumatol 1994; 12: 347-348.
65. Reissman P, Durst AL, Rivkind A, Szold A, Ben-Chetrit E. Elective laparoscopic appendectomy in patients with familial Mediterranean fever. World J Surg 1994; 18: 139-141.
66. Ben-Chetrit E, Levy M. Reproductive system in familial Mediterranean fever: an overview. Ann Rheum Dis 2003; 62: 916-919.
67. Kees S, Langevitz P, Zemer D, Padeh S, Pras M, Livneh A. Attacks of pericarditis as a manifestation of familial Mediterranean fever. QJM 1997; 90: 643-647.
68. Tutar HE, Imamoglu A, Kendirli T, Pwar E, Atalay S, Akar N. Isolated recurrent pericarditis in a patient with familial Mediterranean fever. Eur J Pediatr 2001; 160: 264-265.
69. Eshel G, Vinograd I, Barr J, Zemer D. Acute scrotal pain complicating familial Mediterranean fever in children. Br J Surg 1994; 81: 894-896.
70. Dudkiewicz I, Chechik A, Blankstein A, Salai M. Subtalar arthritis as a presenting symptom of familial Mediterranean fever: case report and literature review. Acta Orthop BeIg 2001; 67: 173-177.
71. Tovi F, Gatot A, Fuss D. Temporo-mandibular arthtritis in familial Mediterranean fever. Head Neck 1992; 14: 492-495.
72. Langevitz P, Livneh A, Zemer D, Shemer J, Pras M. Seronegative spondyloarthropathy in familial Mediterranean fever. Semin Arthritis Rheum 1997; 27: 67-72.
73. Kotevoglu N, Sahin F, Ozkiris SO, Bankaoglu M, Sakiz D, Kuran B. Protracted febrile myalgia of familial Mediterranean fever. Clin Exp Rheumatol 2004; 22: S69-S70.
74. Medlej-Hashim M, Delague V, Chouery E, Salem N, Rawashdeh M, Lefranc G, Loiselet J, Megarbane A. Amyloidosis in familial Mediterranean fever patients with MIEFV genotype and SAA1 and MICA polymorphisms effects. BMC Med Genet 2004; 5:4.
75. Cattan D, Notarnicola C, Molinari N, Touitou I. Inflammatory bowel disease in patients with familial Mediterranean fever. Lancet 2000; 355: 378-379.
76. Bakkaloglu SA, Muzac S, Akpek S, Soylemezoglu O, Buyan N, Hasanoglu E. Polyarteritis nodosa in a case of familial Mediterranean fever. Pediatr Nephrol 2004; 19: 536-538.
77. Lange-Sperandio B, Mohring K, Gutzler F, Mehls O. Variable expression of vasculitis in siblings with familial Mediterranean fever. Pediatr Nephrol 2004; 19: 539-543.
78. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997; 40: 1879-1885.
79. Telatar M, Grody WW. Molecular genetic testing for familial Mediterranean fever. Mol Genet Metab 2000; 71: 256-260.
80. Barakat MH, El-Khawad AO, Gumaa KA, El-Sobki NJ, Fenech FF. Metaraminol provocative test: a specific diagnostic test for familial Mediterranean fever. Lancet 1984; 1: 656-657.
81. Korkmaz C, Ozdogan H, Kasapcopur O, Yazici H. Acute phase response in familial Mediterranean fever. Ann Rheum Dis 2002; 61: 79-81.
82. Zemer D, Pras M, Sohar E, Modan M, Cabili S. Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 1986; 314: 1001-1005.